PTCT · Forms 3, 4, 5
Insider trades at PTC THERAPEUTICS, INC.
3 insiders sold $1.2M of PTC THERAPEUTICS, INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for PTC THERAPEUTICS, INC. (PTCT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 2,118 | $59.52 | $126K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 382 | $60.14 | $23K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Option exercise | 192 | $39.42 | $8K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Sell (10b5-1 plan) | 192 | $64.26 | $12K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 2,447 | $63.38 | $155K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 53 | $63.95 | $3K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Option exercise | 435 | $39.42 | $17K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Sell (10b5-1 plan) | 435 | $64.16 | $28K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Option exercise | 1,638 | $39.42 | $65K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Sell (10b5-1 plan) | 1,638 | $64.03 | $105K | Form 4 | |
| STEELE GLENN JR MD PHD | Director | Option exercise | 12,000 | $11.23 | $135K | Form 4 | |
| STEELE GLENN JR MD PHD | Director | Sell (10b5-1 plan) | 12,000 | $65.16 | $782K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 9,624 | $67.83 | $653K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 376 | $68.45 | $26K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 2,994 | $66.58 | $199K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 7,006 | $67.35 | $472K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 10,000 | $67.34 | $673K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 9,428 | $67.79 | $639K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 572 | $68.67 | $39K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 11,890 | $71.55 | $851K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 610 | $72.22 | $44K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 6,874 | $72.74 | $500K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 5,626 | $73.18 | $412K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 9,419 | $70.78 | $667K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 2,390 | $71.88 | $172K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 691 | $72.92 | $50K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 5,335 | $72.86 | $389K | Form 4 | |
| Michael Schmertzler | Director | Sell (10b5-1 plan) | 7,165 | $73.67 | $528K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Option exercise | 2,813 | $25.69 | $72K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Sell (10b5-1 plan) | 1,844 | $72.39 | $133K | Form 4 | |
| Mark Elliott Boulding | EXEC. VP AND CLO | Sell (10b5-1 plan) | 969 | $72.90 | $71K | Form 4 | |
| Matthew B. Klein | CHIEF EXECUTIVE OFFICER | Sell (10b5-1 plan) | 10,292 | $68.57 | $706K | Form 4 | |
| Hege Elisabeth Sollie-Zetlmayer | Director | Became an insider (Form 3) | Form 3 | ||||
| Hege Elisabeth Sollie-Zetlmayer | Director | Award | 4,000 | Form 4 | |||
| Hege Elisabeth Sollie-Zetlmayer | Director | Award | 2,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.